Imperial College London and Bristol Myers Squibb have teamed up to employ cutting‑edge microscopes that can capture the fleeting, nanoscale events occurring when immune cells encounter diseased cells. The collaboration aims to translate these observations into more effective therapies for cancer and other immune‑related diseases.
Context
Immune system research has traditionally relied on bulk measurements that miss the rapid, sub‑micron interactions between cells. The new microscopy approach allows scientists to see the initial contact points and the tiny protrusions that immune cells use to determine whether a target cell is healthy or diseased.
Key Data
While the study is still in its early stages, the team has identified the immunological synapse—a complex of protein molecules that triggers immune responses—and observed the dynamic detachment of immune cells after they kill a target. These findings suggest that manipulating the spatial arrangement of proteins on immune cell surfaces could amplify their killing power.
Quotes
Daniel Davis, an immunologist at Imperial College London, explained that “We have discovered something that's known as the immunological synapse, which is that lots of different protein molecules are known to trigger the immune system.” He added that “Today’s microscopes reveal worlds that we just had no idea that existed.” Davis also noted that “There's no hierarchy in the system,” emphasizing the individual variability of immune responses.
Outlook
Although the research is still experimental, the partnership signals a promising path toward therapies that can be fine‑tuned to a patient’s unique immune profile. If successful, these advances could lead to more precise and potent treatments for cancer and autoimmune diseases.
